The biomarker human neutrophil lipocalin HNL was previously shown to be a useful indicator of bacterial infections. Now, the ...

Offering a simpler alternative to PET scans and CSF analysis, blood-based biomarker tests could improve accessibility of ...

Now, a team of researchers led by Charité – Universitätsmedizin, in collaboration with colleagues in Berlin and Bonn, has ...

Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients involves trial and error during the treatment process.

Cofactor Genomics has showcased positive data highlighting that its clinical biomarker assay OncoPrism-HNSCC could guide ...

Compass Therapeutics (CMPX) announced its poster presentation entitled “Pharmacodynamic and Response Biomarkers in the Monotherapy Arm of ...

Nurse navigators and APPs are key members of the multidisciplinary team who can lead and implement QI efforts to ensure ...

Results of a study recently published in the journal JCO Precision Oncology show that in the clinical trial context, combined ...

The biomarker human neutrophil lipocalin HNL, which was previously shown to be a useful indicator of bacterial infections, may also in the form of Dimeric HNL be used to effectively monitor the ...

Researchers from Nanjing University and the Army Engineering University of PLA have published a review in ExRNA, shedding ...

Preclinical proof-of-concept data supports the potential of CD3 Switch-DARPin platform to activate and boost T cells in the presence of tumor ...

A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during the SITC annual meeting.